GLPBio

DL-Ethionine

Catalog No.: GD11710Purity:>98.00%
DL-Ethionine, an antagonist of Methionine, is toxic and a carcinogen.

Products are for research use only. Not for human use. We do not sell to patients.


DL-Ethionine
Cas No.: 67-21-0
1gIn Stock
$46.00
1
5gIn Stock
$185.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

DL-Ethionine, an antagonist of Methionine, is toxic and a carcinogen [1]. DL-Ethionine could increase the cyclic AMP content and stimulate the malignant transformation of cells [2]. DL-Ethionine has been widely used to induce hepatocarcinogenesis in rats[3].

In vivo, Feeding a low-choline diet containing 0.5% DL-ethionine resulted in the development of acute hemorrhagic pancreatitis with peritoneal fat necrosis in female mice within five days[4]. DL-Ethionine treatment via intraperitoneal injections for 10 days of DL-Ethionine (0.7mg/g) caused degenerative changes in rat pancreatic acinar tissue, including a widening of the endoplasmic reticulum, a reduction in the number of membrane-bound ribosomes, and the appearance of fine and bulky vacuoles containing nongranular, disordered membranes[5]. C3H female mice given 150mg/kg DL-Ethionine by intubation three times a week for 30 weeks resulted in a significant increase in the incidence of liver tumors[6].

References:
[1] Wang J, Yao H, Lu T, et al. Spectroscopic, kinetic, and theoretical analyses of oxidation of dl-ethionine by Pt (IV) anticancer model compounds[J]. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2019, 223: 117328.
[2] DeRubertis F R, Craven P A. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: Evidence for malignant transformation of liver with a sustained increase in cyclic AMP[J]. Metabolism, 1976, 25(12): 1611-1625.
[3] Kamamoto Y, Makiura S, Sugihara S, et al. The inhibitory effect of copper on DL-ethionine carcinogenesis in rats[J]. Cancer research, 1973, 33(5): 1129-1135.
[4] Lombardi B, Estes L W, Longnecker D S. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet[J]. The American journal of pathology, 1975, 79(3): 465.
[5] Herman L, Fitzgerald P J. The degenerative changes in pancreatic acinar cells caused by DL-ethionine[J]. The Journal of Cell Biology, 1962, 12(2): 277-296.
[6] Hoover K L, Hyde C L, Wenk M L, et al. Ethionine carcinogenesis in CD-1, BALB/c and C3H mice[J]. Carcinogenesis, 1986, 7(7): 1143-1148.

Protocol

Animal experiment [1]:

Animal models

Male albino rats

Preparation Method

One hundred and fifty male albino rats, Wistar strain, weighing 160 to 180g, were given water ad libitum and kept in individual cages in an air-conditioned room at 68°F. One hundred and twenty-five of the rats were placed on a protein-free diet. Seventy-five of the rats on the protein-free diet received daily intraperitoneal injections for 10 days of DL-Ethionine (0.7mg/g) dissolved in aqueous 0.9 sodium chloride (ethionine group). Fifty mice were kept on the protein-free diet. After day 10, the mice of both the DL-Ethionine and protein-free groups were maintained on the protein-free diet through day 28. The status of pancreatic acinar tissues in rats injected with ethionine was analyzed.

Dosage form

0.7mg/g/day for 10 days; i.p.

Applications

DL-Ethionine treatment caused degenerative changes in rat pancreatic acinar tissue, including a widening of the endoplasmic reticulum, a reduction in the number of membrane-bound ribosomes, and the appearance of fine and bulky vacuoles containing nongranular, disordered membranes.

References:
[1] Herman L, Fitzgerald P J. The degenerative changes in pancreatic acinar cells caused by DL-ethionine[J]. The Journal of Cell Biology, 1962, 12(2): 277-296.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
67-21-0
Molecular Formula
C6H13NO2S
Molecular Weight
163.238
Storage
-20°C, protect from light, away from moisture
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for DL-Ethionine

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%